Results 101 to 110 of about 278,985 (182)

Inhibitory effects of dopamine agonists on pain-responsive neurons in the central nucleus of the amygdala. [PDF]

J Neurophysiol
Heuermann RJ, Gereau RW.
europepmc   +1 more source

Dopamine Agonist [PDF]

, 2020
openaire   +1 more source

p300-mediated histone H3K18 lactylation promotes mitochondrial ROS accumulation via mitophagy inhibition to potentiate dopamine agonists efficacy in prolactinomas. [PDF]

Redox Biol
Li S, Jiang Q, Wang Q, Li X, Wang Z, Xu L, Luo S, Wang Y, Zhang H, Shu K, Lei T, Huang Y, Lei Z.   +12 more
europepmc   +1 more source

The effects of dopamine agonists and antagonists on the secretory responses in the salivary glands of the locust (Locusta migratoria)

, 2004
A study has been made on the effect of dopamine on salivary gland secretion rates from isolated locust salivary glands. Application of dopamine induced a concentration-dependent secretion with an IC50 of approximately 0.3 μM.
Orchard, Ian, Keating, Christopher
core  

Long-term Outcome of Microscopic Transsphenoidal Surgery for Prolactinomas as an Alternative to Dopamine Agonists. [PDF]

J Korean Med Sci, 2021
Park K, Park KH, Park HR, Lee JM, Kim YH, Kim DY, Won TB, Kong SH, Kim JH, Shin CS, Paek SH.   +10 more
europepmc   +1 more source

Cholesterol-activated stress granules reduce the membrane localization of DRD2 and promote prolactinoma dopamine agonists resistance. [PDF]

Acta Neuropathol Commun
Peng Y, Yin H, Pei X, Zhang Y, Wang C, Zheng X, Liang H, Yang H, Li S.   +8 more
europepmc   +1 more source

Dopamine Agonists as a Novel "Cure" for Autoimmune Diabetes. [PDF]

JCEM Case Rep
Sahota S, Cooper L, Sirkova A, Stojanovic N.   +3 more
europepmc   +1 more source

Impulse control disorders in patients with pituitary adenoma managed with or without dopamine agonists: a cross-sectional study from a UK centre. [PDF]

Pituitary
Hamblin R, White M, Fountas A, Karavitaki N.   +3 more
europepmc   +1 more source

Comparative safety signals of dopamine agonists: psychiatric and cardiovascular risks derived from FDA adverse event reporting system (FAERS) data. [PDF]

BMC Pharmacol Toxicol
Mu L, Xu J, Ye X, Jiang Y, Yi Z.
europepmc   +1 more source

Cortico-striatal circuit mechanisms drive the effects of D1 dopamine agonists on memory capacity in mice through cAMP/PKA signalling. [PDF]

Nat Commun
De Risi M, Cavezza D, Torromino G, Capalbo A, Cundin XB, Di Martino R, Alvino FG, Iemolo A, Speranza L, Perrone-Capano C, Crispino M, Cirillo C, Luini A, Sacco F, Grumati P, De Leonibus E.   +15 more
europepmc   +1 more source